,0,1
0,[1],"2012 includes the recognition of a $3,340 million impairment charge related to the carrying value of Citi's then-remaining 35% interest in the Morgan Stanley Smith Barney joint venture (MSSB), as well as the recognition of a $1,181 million impairment charge related to Citi's investment in Akbank. The remaining MSSB interest was sold during 2013. See Note 14 to the Consolidated Financial Statements."
1,[2],"Other revenue for 2012 includes a $1,344 million loss related to the sale of a 14% interest in MSSB, as well as the recognition of a $424 million loss related to the sale of a 10.1% stake in Akbank T.A.S. See Note 14 to the Consolidated Financial Statements."
2,[3],"Citigroup recorded repositioning charges of $590 million for 2013, $1,375 million for 2012 and $706 million for 2011."
3,[4],"All per share amounts and Citigroup shares outstanding for all periods reflect Citigroup's 1-for-10 reverse stock split, which was effective May 6, 2011."
4,[5],"Due to rounding, earnings per share on continuing operations and discontinued operations may not sum to earnings per share on net income."
